Results 21 to 30 of about 29,241 (216)

Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis

open access: yesJournal of Translational Autoimmunity, 2023
Introduction: Rituximab monotherapy represents the main therapeutic option for cryoglobulinemic vasculitis (CV) with severe organ involvement. However, initial worsening of the CV, known as rituximab-associated CV flare (=CV flare), has been described ...
Léa Fornero   +9 more
doaj   +1 more source

Reducing the economic burden in management of Guillain–Barre syndrome using modified plasmapheresis

open access: yesAsian Journal of Transfusion Science, 2016
Background: Guillain–Barre syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy affecting the peripheral nervous system treated with high-dose immunoglobulin, physical therapy, or plasmapheresis.
Rekha Ramaswamy Iyer   +3 more
doaj   +1 more source

Plasmapheresis in Acute Fatty Liver of Pregnancy: An Effective Treatment

open access: yesCase Reports in Obstetrics and Gynecology, 2013
Acute fatty liver of pregnancy (AFLP) is an idiopathic disorder with an unknown cause occurring in late pregnancy. The treatment in these patients is often immediate termination of pregnancy, and plasmapheresis provides an effective treatment option.
Mohammad Reza Seyyed Majidi   +1 more
doaj   +1 more source

Source Plasma Donation: The Experience of the Iranian Blood Transfusion Organization

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2022
Background: A declining need for red blood cells coupled with strengthening demand for plasma-derived medicines has led to a strong focus on moving whole blood donors to plasmapheresis. The purpose of this study was to evaluate the four-year policies of
Saeed Mohammadi   +5 more
doaj  

Association of regular plasmapheresis donation with serum protein and electrolyte levels: a multicentre cross-sectional study in China

open access: yesBMJ Open
Background China’s plasmapheresis donation policy differs from that of Western countries. The association between regular plasmapheresis donation and donor health in China is still unknown.Objectives To investigate the association of regular ...
Yu Zhang   +13 more
doaj   +1 more source

Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation

open access: yesKidney Research and Clinical Practice, 2017
Background: Plasmapheresis has become an essential element of kidney transplantation (KT). In the present study, we report clinical outcomes of filtration plasmapheresis using continuous renal replacement therapy machines with a single filter for the ...
Eunsoo Lim   +7 more
doaj   +1 more source

The comparison of the mortality rates of plasmapheresis/hemoperfusion therapy with current treatment among Covid-19 patients

open access: yesHeliyon, 2022
Background: There is no definitive treatment for COVID-19. Hemoperfusion and plasmapheresis have only been studied in a few cases of COVID-19. In this study, plasmapheresis-hemoperfusion and current treatment for COVID-19 patients were compared for ...
Seyede Mahboobeh Raoofi Kelachayeh   +5 more
doaj   +1 more source

Bone density and bone metabolism in plasmapheresis donors

open access: yesZhongguo shuxue zazhi
Objective To investigate the level of serum bone metabolism and biochemical markers and bone density of plasmapheresis donors, and to provide scientific basis for ensuring the health and safety of plasmapheresis donors in China.
Wan LI   +5 more
doaj   +1 more source

Application of biological age assessment of Chinese population in potential anti-ageing technology

open access: yesImmunity & Ageing, 2018
Background This study aimed to construct a biological age assessment formula for the Chinese population and to explore the effectiveness of double filtration plasmapheresis for anti-ageing and longevity. Methods 915 subjects were recruited, including 584
Xufeng Li   +7 more
doaj   +1 more source

Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature

open access: yesTherapeutic Advances in Endocrinology and Metabolism, 2017
Background: Severe hypertriglyceridemia (HTG) is the third leading cause of acute pancreatitis (AP) in the United States. The current standard of care includes management of HTG using pharmacological therapy.
Kiran Joglekar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy